Analyst firms · Citizens JMP · APYX
Citizens JMP APYX price target and rating history
Apyx Medical Corporation (APYX) · Health Care
Citizens JMP rates Apyx Medical Corporation (APYX) Mkt Outperform with a $8 price target, as of its latest action on Nov 14, 2025. It has published 3 rating actions on APYX since August 2021, including 2 upgrades and 0 downgrades. Across 4 firms with a APYX price target in the last 12 months, the median target is $6.
- Current rating
- Mkt Outperform
- Price target
- $8
- Median target, all firms
- $6
- Actions on APYX
- 3
Citizens JMP price target on APYX
Every Citizens JMP rating on APYX
- Nov 14, 2025
- Nov 12, 2025
- Aug 13, 2021
How other firms rate APYX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Maxim Group | Buy | $6 | Sep 29, 2026 |
| H.C. Wainwright | Buy | $7 | Jul 13, 2026 |
| BTIG | Buy | $6 | Mar 11, 2026 |
| Roth Capital | Buy | $6 | Dec 16, 2025 |
Questions about Citizens JMP and APYX
- What is Citizens JMP's price target for APYX?
- Citizens JMP's latest stated price target for Apyx Medical Corporation (APYX) is $8, from its action on Nov 12, 2025.
- What is Citizens JMP's rating on APYX?
- Citizens JMP rates APYX Mkt Outperform, a bullish rating, as of Nov 14, 2025.
- When did Citizens JMP last change its view on APYX?
- On Nov 14, 2025, Citizens JMP upgrades to Mkt Outperform from Mkt Perform.
- How does Citizens JMP's APYX target compare with other analysts?
- Across 4 firms with a APYX price target in the last 12 months, the median target is $6.
All Citizens JMP ratingsAPYX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.